Ultime notizie per California (OTC:CANOF) Azioni

California Nanotechnologies Corp engages in the production, and research and development of nanostructured components and materials. Its products include precision forged components, thermal spray powders, nano light alloy powders, nanoalloy billets, nano superalloy powders, cemented carbides, and tooling. The company products are used in Aerospace, Defense, Automotive, Medical, and Sport and Recreation industries. It has extensive experience in dozens of R&D and pilot production projects with Industrial partners, National Labs, and Universities.

CALIFORNIA NANOTECHS CORP by California Nanotechnologies Corp

California Nanotechnologies Corp

Honeywell Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) has outperformed the market over the past 20 years by 1.3% on an annualized basis producing an average annual return of 9.5%. Currently, Honeywell Intl has a market capitalization of $135.04 billion. 
Buying $1000 In HON: If an investor had bought $1000 of HON stock 20 years ago, it would be worth $6,079.79 today based on a price of $209.93 for HON at the time of writing.
<h3>Honeywell Intl's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746566121_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Wynn Resorts, Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>) reported first-quarter financial results Tuesday after the bell. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/05/b45234840/wynn-resorts-limited-reports-first-quarter-2025-results">of the report</a>.
<ul>
<li>Q1 Revenue: $1.7 billion, versus <a href="https://www.benzinga.com/quote/WYNN/earnings">estimates</a> of $1.74 billion</li>
</ul>
<ul>
<li>Q1 Adjusted EPS: $1.07, versus estimates of $1.19</li>
</ul>
Total revenue was down from $1.86 billion in the first quarter of 2024. Operating revenue at Wynn Macau fell $81.8 million in the quarter, Wynn Palace revenue declined $51 million, Las Vegas revenue dropped $11.3 million and Boston Harbor revenue was down $8.6 million. 
Wynn Resorts ended the quarter with $2.07 billion in cash and cash equivalents, as well as $10.55 billion in current and long-term debt outstanding. 
&#8220;In Las Vegas, where we recently celebrated the resort&#8217;s 20th anniversary, the team delivered healthy results against a record prior year comparison, which reflected the Las Vegas Super Bowl. In Macau, while VIP hold negatively impacted results, we held market share in our expected range, and announced an increased dividend from Wynn Macau, Limited, reflecting the strong free cash flow generated by the business,&#8221; said Craig Billings, CEO of Wynn Resorts.
See Also: <a href="https://www.benzinga.com/news/earnings/25/05/45237261/amd-q1-earnings-revenue-eps-beat-driven-by-expanding-data-center-ai-momentum-chipmaker-expects-strong-growth-in-2025">AMD Q1 Earnings: Revenue, EPS Beat Driven By Expanding Data Center, AI Momentum, Chipmaker Expects &#8216;Strong Growth&#8217; In 2025</a>
Wynn noted that it repurchased $200 million worth of its stock during the quarter, and had $613 remaining under its buyback as of March 31. The company&#8217;s board also declared a cash dividend of 25 cents per share, payable on May 30 to shareholders of record as of May 16. 
Wynn highlighted progress at its growth project in the United Arab Emirates, Wynn Al Marjan Island. The company said it continued to advance construction in the quarter with progress reaching the 47th floor. 
Wynn executives are currently discussing the quarter on a conference call that kicked off at 4:30 p.m. ET.
WYNN Price Action: <a href="http://benzinga.com/quote/wynn">Wynn Resorts shares</a> were down 2.42% in extended trading on Tuesday, trading at $81.50 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://in.benzinga.com/25/05/45207560/expedia-faces-turbulence-as-us-travel-trend-weakens-says-analyst">Expedia Faces Turbulence As US Travel Trend Weakens, Says BofA Analyst</a></li>
</ul>
Photo: Ceri Breeze/Shutterstock.

Earnings

Entertainment

After-Hours Center

Movers

WYNN

Wynn Resorts Misses Q1 Earnings Estimates, Shares Slide

Lattice Semiconductor Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) stock fell on Tuesday.
The company reported its <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45208613/lattice-semiconductor-shares-slide-after-q1-results-details" rel="noreferrer noopener">first-quarter results</a> after Monday&#8217;s closing bell<a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45205997/lattice-semiconductor-reports-first-quarter-2025-results" rel="noreferrer noopener">, </a>clocking a quarterly earnings of 22 cents per share, which aligns with the analyst consensus estimate.
Quarterly revenue was $120.15 million (down from $140.81 million Y/Y), which beat the analyst consensus estimate of $120.13 million.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45208613/lattice-semiconductor-shares-slide-after-q1-results-details" rel="noreferrer noopener">Lattice Semiconductor Shares Slide After Q1 Results: Details</a>
Lattice Semiconductor expects second-quarter adjusted earnings of between 22 cents and 26 cents per share, versus the 24 cents estimate, and revenue of&nbsp;$118.5 million-$128.5 million, versus the&nbsp;$123.61 million&nbsp;analyst estimate.
Wall Street analysts rerated the stock after the quarterly report.
Rosenblatt analyst Kevin Garrigan maintained a Buy rating on Lattice Semiconductor with a <a target="_blank" href="https://www.benzinga.com/quote/LSCC/analyst-ratings" rel="noreferrer noopener">price forecast of $72</a>.
Growth across Industrial &amp; Automotive and Consumer end-markets drove the sequential revenue increase, while Communications &amp; Computing declined slightly. Additionally, design win momentum remained at record levels. The adjusted gross margin was 69% (+700bps Q/Q, flat Y/Y), which aligns with Garrigan&#8217;s 69.0% estimate and slightly below the consensus 70.1% estimate.
Management reiterated its U-shaped recovery and expects low single-digit Y/Y revenue growth in 2025.
The company continues to ship below true demand in the near term and is encouraged by continued booking improvement. Channel inventory also continues to decrease.
Management commented that they do not see any material impact from tariffs but are more cautious about the effect in the second half of 2025.
Additionally, ~80% of Lattice&#8217;s revenue comes from outside the US, and Lattice has a diversified global supply chain, helping mitigate any direct impacts from tariffs.
Management expects continued recoveries in Industrial &amp; Automotive markets and growth in Communications &amp; Computing.
Garrigan continues to recommend Lattice Semiconductor shares for its robust design win pipeline, new product momentum, and share gains in the small/mid-FPGA market.
Garrigan projected second-quarter revenue of $123.5 million and EPS of $0.24.
Price Action: LSCC stock closed lower by 12.7% at $45.82 on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45196679/nvidia-faces-new-challenges-as-us-tightens-semiconductor-sanctions-and-tracks-ai-chip-smuggling" target="_blank" rel="noreferrer noopener">Nvidia&#8217;s New Challenge: US Lawmaker Wants Company To Track Its Chips To Avoid Smuggling In China</a></li>
</ul>
Photo via Shutterstock

Analyst Color

Price Target

Reiteration

Analyst Ratings

LSCC

Why Did Lattice Semiconductor Stock Plunge On Tuesday?

Considered to be one of the <a href="https://chain.link/education-hub/real-world-assets-rwas-explained">biggest </a>market opportunities within the blockchain industry, tokenized real-world assets (RWAs) are expected to transform the real estate sector in the foreseeable future. 
In fact, <a href="https://www2.deloitte.com/us/en/insights/industry/financial-services/financial-services-industry-predictions/2025/tokenized-real-estate.html">according </a>to a Deloitte Center for Financial Services report, the global value of tokenized real estate is predicted to reach US$4trillion by 2035. 
While these estimates are based on assumptions of sub segment-wise tokenization penetration rates, the total tokenized real estate market size could encompass the entire commercial real estate market volume that is <a href="https://www.statista.com/outlook/fmo/real-estate/commercial-real-estate/worldwide">projected </a>to reach $120 trillion in 2025. 
Considering this huge upside potential, many blockchain platforms are leveraging decentralized finance (DeFi) infrastructure to make tokenized real estate more accessible, liquid and efficient.
How Tokenization Is Opening New Avenues For Real Estate Investment
With a current size of under US$300billion, the tokenized real estate market is projected to grow at a 27% CAGR over the next decade, driven by tangible demand for digital real estate assets that can be easily traded, financed or even used as collateral. 
At the forefront of this revolution are a number of public EVM-compatible blockchains that are building demand-driven, transparent and secure financial ecosystems that are optimized for RWAs. 
These vertically integrated platforms not only enable issuers to tokenize assets like land, real estate bonds and loans; but also provide tools for compliance, transparency and interoperability to ensure their efficient distribution across different blockchains. 
What's more, these blockchains are home to vast networks of crypto projects that are focused on enhancing the utility and accessibility of RWAs, in turn unlocking new yield-bearing investment opportunities for retail investors.
For institutional investors, real estate asset tokenization is supporting portfolio diversification, ensuring increased asset liquidity and opening up previously inaccessible real estate markets by facilitating seamless cross-border transactions using digital tokens. 
It is also significantly lowering private investment thresholds by fractionalizing ownership of private real estate funds, securitized loans, residential real estate as well as infrastructure projects, thereby triggering a second wave of private market democratization by opening up real estate investments to a wider audience.
Full-Stack Blockchain Platforms And Their Role In Supporting Real Estate Tokenization
While an increasing number of projects are offering real estate tokenization products and services, full-stack blockchain platforms continue to play a pivotal role in streamlining the tokenization lifecycle for real estate developers, fund managers, institutional investors as well as retail consumers. 
With purpose-built architectures that bring real-world data on-chain and offer a secure environment for managing RWAs, these platforms are ideal for supporting the development of innovative tokenization use cases with extensive regulatory compliance. 
Moreover, by relying on smart contracts to govern legal and economic claims against the underlying asset, users can customize token functionalities and enjoy faster transactions. 
In fact, full-stack blockchain platforms are focused on the composability of RWAs, allowing digital assets to interact seamlessly across different DeFi applications and protocols, thereby facilitating the development of complex, yield-bearing financial instruments that meet diverse investor needs.
Solving Compliance And Scalability Challenges To Facilitate Global Participation
In the process of tokenizing real estate assets, asset issuers must comply with information disclosure norms as mandated by the U.S Securities and Exchange Commission (SEC) while also complying with different sets of regulatory restrictions. 
Depending on the size of token issuance, and investor type, different forms need to be filled depending on the SEC regulation under which an issuer would like to raise capital, with additional broker and transfer agent requirements that need to be met for compliance. 
Additionally, with many countries still devoid of specific regulations to govern tokenized real estate, both asset issuers and investors can often face legal uncertainties that complicate regulatory compliance. 
To resolve these challenges, full-stack blockchain platforms are collaborating with FINRA-registered brokers, SEC-licensed transfer agents, exchanges and law firms to offer issuers consulting services.
From a scalability perspective, blockchain platforms rely on core components including a tokenization engine, smart wallets and a data highway to integrate offchain data &amp; insights directly into the blockchain. 
While the tokenization engine simplifies token creation, user onboarding and subsequent management of RWAs, smart wallets abstract custody and compliance functions to streamline the end-user experience. 
These smart wallets offer users access to advanced DeFi functionalities while maintaining complete control over their onchain assets. Moreover, the steady flow of real-time asset-related data can be leveraged by users to take advantage of new use cases in prediction markets, enhancing the overall value and functionality of RWAs. 
This is helping develop fund structures that allow real-time reporting, intraday liquidity and programmable compliance; in turn accelerating the participation of crypto-native firms and legacy fund managers in tokenized real estate.
Blockchain firms that are building foundational elements to increase cross-chain interoperability, maintain regulatory compliance and abstract legal &amp; infrastructure complexity will lead the way in powering rapid expansion of the tokenized real estate market. 
This should bode well for retail and institutional investors alike and unlock new opportunities for global participation in real estate asset ownership.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Opinion

Real Estate

How Public Blockchains Are Powering Tokenized Real Estate Ecosystems And Unlocking Global Capital Access

Suncor Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SU#NYSE">SU</a>) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.86 by 5.81 percent. This is a 13.33 percent decrease over earnings of $1.05 per share from the same period last year. The company reported quarterly sales of $8.68 billion which beat the analyst consensus estimate of $8.34 billion by 4.02 percent. This is a 6.68 percent decrease over sales of $9.30 billion the same period last year.

Earnings Beats

Suncor Energy Q1 Adj. EPS $0.91 Beats $0.86 Estimate, Sales $8.68B Beat $8.34B Estimate

Bristow Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTOL#NYSE">VTOL</a>) affirms FY2025 sales outlook from $1.42 billion-$1.61 billion to $1.42 billion-$1.61 billion vs $1.56 billion estimate.

Guidance

VTOL

Bristow Group Affirms FY2025 Sales Guidance of $1.42B-$1.61B vs $1.56B Est

Bristow Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTOL#NYSE">VTOL</a>) affirms FY2026 sales outlook from $1.52 billion-$1.77 billion to $1.52 billion-$1.77 billion vs $1.70 billion estimate.

Bristow Group Affirms FY2026 Sales Guidance of $1.52B-$1.77B vs $1.70B Est

System1 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SST#NYSE">SST</a>) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.32) by 34.38 percent. This is a 53.33 percent increase over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $74.51 million which beat the analyst consensus estimate of $69.87 million by 6.64 percent. This is a 12.25 percent decrease over sales of $84.92 million the same period last year.

System1 Q1 EPS $(0.21) Beats $(0.32) Estimate, Sales $74.51M Beat $69.87M Estimate

WIIM

Gen Digital shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 and Q1 guidance above estimates.

Earnings Misses

American Finl Gr Q1 Adj. EPS $1.81 Misses $2.03 Estimate, Sales $1.58B Miss $1.74B Estimate

PSX Leadership Supports Poor Performance and the Status Quo&nbsp;
Elliott's "Streamline 66" Plan Would Create a Stronger Phillips 66 Based on Experience and Results, Not Rhetoric&nbsp;
Visit <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4421548-1&amp;h=103704435&amp;u=https%3A%2F%2Fstreamline66.com%2Fpresentations%2F&amp;a=Streamline66.com">Streamline66.com</a> to Download the Full Presentation
WEST PALM BEACH, Fla., May 6, 2025 /PRNewswire/ -- Elliott Investment Management L.P. ("Elliott"), which manages funds that together make it a top-five shareholder in Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) (the "Company" or "Phillips"), today released an investor presentation titled "Streamline 66: The Choice for Shareholders."
Elliott presented Phillips 66 shareholders with a simple choice ahead of the Annual General Meeting on May 21st. Do shareholders want to support the current leadership team, which considers its performance acceptable and is committed to the status quo? Or do shareholders want to elect shareholder-nominated directors empowered to drive accountability and improve long-term performance?

Management

Elliott Management Presents The Choice For Phillips 66 Shareholders; Says "Streamline 66" Plan Would Create A Stronger Phillips 66 Based On Experience And Results, Not Rhetoric

ANET

Arista Networks shares are trading lower after the company reported a Q1 sales miss.

Tempus AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) reported first-quarter financial results Tuesday after the market close. Here&#8217;s a look at the key details <a href="https://www.benzinga.com/pressreleases/25/05/b45234780/tempus-reports-first-quarter-2025-results">from the report</a>.
Q1 Earnings: Tempus AI reported first-quarter revenue of $255.74 million, beating&nbsp;<a href="https://www.benzinga.com/quote/TEM/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $248.13 million. The AI-focused precision medicine and patient care company reported a first-quarter adjusted loss of 24 cents&nbsp;per share, beating analyst estimates for a loss of 27 cents&nbsp;per share, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Total revenue was up 75.4% year-over-year as genomics revenue grew 88.9% year-over-year to $193.8 million. Data and services revenue grew 43.2% to $61.9 million, led by Insights (data licensing), which grew&nbsp;58%&nbsp;year-over-year.
Tempus AI highlighted multi-year strategic collaborations with AstraZeneca and Pathos, resulting in an additional $200 million in data licensing and model development fees over the next three years. The company had approximately $151.6 million in cash and equivalents at the quarter's end.
&#8220;The business is performing well with revenues growing, margins improving, and our costs remaining in check, allowing us to demonstrate significant year-over-year operating leverage,&#8221; said&nbsp;Eric Lefkofsky, founder and CEO of Tempus AI.
&#8220;Our strategic investments in AI have us uniquely positioned to advance what is possible in diagnostics and drug development, as evidenced by our announcement to build the largest foundation model in oncology with AstraZeneca and Pathos. We believe this is just the beginning as more and more healthcare providers and life science companies embrace AI.&#8221;
Outlook: Tempus AI raised its full-year 2025 revenue guidance from $1.24 billion to $1.25 billion for its consolidated Tempus and Ambry Genetics business, which represents approximately 80% annual growth.
The company continues to expect full-year 2025 adjusted EBITDA of $5 million, versus a full-year adjusted EBITDA loss of $104.7 million in full-year 2024.
Tempus AI executives will further discuss the company&#8217;s quarterly results on a conference call set for 4:30 p.m. ET
TEM Price Action: <a href="http://benzinga.com/quote/ai" target="_blank" rel="noreferrer noopener">Tempus AI shares</a> were up 5.79% after hours, trading at $55.21 at the time of publication on Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/insights/analyst-ratings/25/04/44976660/beyond-the-numbers-9-analysts-discuss-tempus-ai-stock">Beyond The Numbers: 9 Analysts Discuss Tempus AI Stock</a></li>
</ul>
Photo: Piotr Swat/Shutterstock.

Health Care

Tempus AI Q1 Earnings: Revenue Beat, EPS Beat, Raised FY Guidance, Shares Surge

Corpay (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>) is looking for Q2 Adj EPS of $5.05-$5.15 vs $5.13 analyst estimate..

CPAY

Corpay Sees Q2 Adj EPS $5.05-$5.15 vs $5.13 Est

Forrester Res (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORR#NASDAQ">FORR</a>) lowers FY2025 GAAP EPS guidance from $0.24-$0.34 to $(4.23)-$(4.08) vs $0.30 analyst estimate..

FORR

Forrester Res Lowers FY2025 GAAP EPS Guidance from $0.24-$0.34 to $(4.23)-$(4.08) vs $0.30 Est

<h3>Gainers</h3>
<ul>
<li>Netclass Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTCL#NASDAQ">NTCL</a>) shares rose 73.7% to $57.32 during Tuesday's after-market session. The company's market cap stands at $1.0 billion. </li>
<li>Purple Innovation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPL#NASDAQ">PRPL</a>) shares increased by 20.22% to $0.89. The company's market cap stands at $96.8 million. As per the news, the Q1 earnings report came out today. </li>
<li>QVC Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QVCGA#NASDAQ">QVCGA</a>) stock moved upwards by 13.95% to $0.27. The company's market cap stands at $110.3 million. </li>
<li>Wah Fu Education Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAFU#NASDAQ">WAFU</a>) shares rose 13.15% to $1.57. The company's market cap stands at $6.9 million. </li>
<li>Aureus Greenway Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGH#NASDAQ">AGH</a>) stock rose 12.03% to $0.69. The market value of their outstanding shares is at $9.6 million. </li>
<li>Vision Marine Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>) stock moved upwards by 9.76% to $6.97. The company's market cap stands at $7.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>WW International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WW#NASDAQ">WW</a>) stock declined by 39.7% to $0.48 during Tuesday's after-market session. The market value of their outstanding shares is at $38.2 million. As per the news, the Q1 earnings report came out today. </li>
<li>Lixiang Education Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) stock decreased by 27.23% to $2.54. The company's market cap stands at $2.9 million. </li>
<li>MKDWell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKDW#NASDAQ">MKDW</a>) shares declined by 15.3% to $0.28. The market value of their outstanding shares is at $40.8 million. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) shares fell 10.7% to $0.47. The market value of their outstanding shares is at $135.4 million. </li>
<li>Revolve Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVLV#NYSE">RVLV</a>) stock decreased by 10.62% to $16.93. The market value of their outstanding shares is at $1.2 billion. The company's, Q1 earnings came out today. </li>
<li>Mingteng International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEN#NASDAQ">MTEN</a>) stock decreased by 6.05% to $11.51. The company's market cap stands at $78.7 million. The company's, FY earnings came out 4 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LXEH

MKDW

MTEN

NTCL

NWTN

PRPL

QVCGA

RVLV

VMAR

WAFU

12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session

System1 shares are trading higher following a Q1 sales beat.

<h3>Gainers</h3>
<ul>
<li>Lipocine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPCN#NASDAQ">LPCN</a>) shares rose 15.1% to $3.66 during Tuesday's after-market session. The company's market cap stands at $19.5 million. </li>
<li>Cumberland (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPIX#NASDAQ">CPIX</a>) shares increased by 11.11% to $4.9. The market value of their outstanding shares is at $68.4 million. As per the news, the Q1 earnings report came out today. </li>
<li>Rigel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIGL#NASDAQ">RIGL</a>) shares moved upwards by 10.89% to $20.25. The market value of their outstanding shares is at $356.7 million. The company's, Q1 earnings came out today. </li>
<li>Harvard Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBIO#NASDAQ">HBIO</a>) stock moved upwards by 10.0% to $0.33. The company's market cap stands at $14.5 million. </li>
<li>OneMedNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) shares moved upwards by 9.84% to $0.42. The company's market cap stands at $11.8 million. </li>
<li>Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) shares rose 9.35% to $0.49. The market value of their outstanding shares is at $71.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) stock fell 20.7% to $37.0 during Tuesday's after-market session. The company's market cap stands at $3.6 billion. The company's, Q1 earnings came out today. </li>
<li>Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) stock decreased by 18.44% to $5.93. The company's market cap stands at $546.5 million. As per the news, the Q1 earnings report came out today. </li>
<li>AquaBounty Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQB#NASDAQ">AQB</a>) shares decreased by 16.87% to $0.78. The market value of their outstanding shares is at $3.0 million. </li>
<li>Evoke Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) stock fell 8.82% to $3.0. The company's market cap stands at $4.4 million. </li>
<li>Tharimmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THAR#NASDAQ">THAR</a>) stock fell 8.49% to $1.51. The market value of their outstanding shares is at $2.9 million. </li>
<li>180 Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNF#NASDAQ">ATNF</a>) shares fell 8.48% to $1.08. The company's market cap stands at $4.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATNF

BDSX

CPIX

EVOK

HBIO

LPCN

MYGN

ONMD

RIGL

SRPT

THAR

12 Health Care Stocks Moving In Tuesday's After-Market Session

Corpay (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>) is looking for Q2 GAAP EPS of $3.82-$3.92 vs $4.11 analyst estimate..

Corpay Sees Q2 GAAP EPS $3.82-$3.92 vs $4.11 Est

Ashford Hospitality Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHT#NYSE">AHT</a>) reported quarterly losses of $(0.98) per share which missed the analyst consensus estimate of $5.86 by 116.72 percent. This is a 72 percent increase over losses of $(3.50) per share from the same period last year. The company reported quarterly sales of $277.36 million which missed the analyst consensus estimate of $319.00 million by 13.05 percent. This is a 8.73 percent decrease over sales of $303.90 million the same period last year.

Comments

California

Notizie

Ultime notizie per California (OTC:CANOF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO